FDA Clears Argus Cognitive's Neurora to Support Autism Diagnosis in Children Ages 18 Months Through 12 Years
Business Wire
The FDA has cleared Argus Cognitive's Neurora device to aid in the diagnosis of autism in children aged 18 months to 12 years. Neurora uses electroencephalography (EEG) to analyze brain activity and provide objective data to support clinical assessments. This marks the first FDA-cleared medical device specifically designed to assist in autism diagnosis in this age group.
All articles from 8 October 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.